H.U. Group Holdings Zukünftiges Wachstum
Future Kriterienprüfungen 3/6
H.U. Group Holdings is forecast to grow earnings and revenue by 70% and 3.5% per annum respectively. EPS is expected to grow by 70% per annum. Return on equity is forecast to be 5.6% in 3 years.
Wichtige Informationen
70.0%
Wachstumsrate der Gewinne
70.0%
EPS-Wachstumsrate
Healthcare Gewinnwachstum | 20.1% |
Wachstumsrate der Einnahmen | 3.5% |
Zukünftige Eigenkapitalrendite | 5.6% |
Analystenabdeckung | Good |
Zuletzt aktualisiert | 28 Aug 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
Gewinn- und Umsatzwachstumsprognosen
Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
---|---|---|---|---|---|
3/31/2027 | 262,134 | 7,527 | 13,766 | 22,398 | 6 |
3/31/2026 | 252,599 | 5,204 | 12,921 | 21,838 | 6 |
3/31/2025 | 243,291 | 3,831 | 12,676 | 23,623 | 6 |
3/31/2024 | 236,950 | -7,553 | -1,006 | 16,551 | N/A |
12/31/2023 | 237,456 | -6,458 | 7,264 | 22,725 | N/A |
9/30/2023 | 243,370 | -1,699 | 4,485 | 22,297 | N/A |
6/30/2023 | 252,197 | 8,969 | 1,162 | 20,243 | N/A |
3/31/2023 | 260,908 | 15,676 | 10,849 | 32,535 | N/A |
12/31/2022 | 276,026 | 22,870 | 7,113 | 36,048 | N/A |
9/30/2022 | 273,286 | 25,633 | 20,412 | 50,133 | N/A |
6/30/2022 | 274,783 | 26,843 | 22,139 | 55,675 | N/A |
3/31/2022 | 272,944 | 29,599 | 20,104 | 55,229 | N/A |
12/31/2021 | 259,808 | 30,266 | 24,279 | 54,007 | N/A |
9/30/2021 | 258,189 | 31,885 | 18,863 | 46,670 | N/A |
6/30/2021 | 242,604 | 27,194 | 23,061 | 47,458 | N/A |
3/31/2021 | 223,016 | 17,468 | 14,400 | 35,588 | N/A |
12/31/2020 | 207,955 | 9,077 | 9,573 | 27,221 | N/A |
9/30/2020 | 193,798 | 2,042 | 2,379 | 20,128 | N/A |
6/30/2020 | 186,332 | -3,054 | -9,004 | 7,478 | N/A |
3/31/2020 | 188,712 | -516 | -336 | 15,229 | N/A |
12/31/2019 | 188,014 | 2,733 | 251 | 15,923 | N/A |
9/30/2019 | 185,231 | 4,457 | -6,158 | 10,301 | N/A |
6/30/2019 | 182,727 | 5,697 | -5,853 | 14,890 | N/A |
3/31/2019 | 181,415 | 6,386 | -10,465 | 16,244 | N/A |
12/31/2018 | 178,473 | 886 | -19,173 | 11,332 | N/A |
9/30/2018 | 181,159 | 9,801 | -13,180 | 16,227 | N/A |
6/30/2018 | 188,204 | -2,499 | -9,105 | 16,038 | N/A |
3/31/2018 | 195,400 | 257 | -1,527 | 15,767 | N/A |
12/31/2017 | 202,563 | 6,272 | N/A | 21,755 | N/A |
9/30/2017 | 205,497 | 359 | N/A | 27,058 | N/A |
6/30/2017 | 204,346 | 2,948 | N/A | 30,600 | N/A |
3/31/2017 | 204,245 | 333 | N/A | 36,436 | N/A |
12/31/2016 | 206,217 | 5,091 | N/A | 35,250 | N/A |
9/30/2016 | 208,413 | -16,703 | N/A | 33,322 | N/A |
6/30/2016 | 211,076 | -7,065 | N/A | 34,120 | N/A |
3/31/2016 | 211,743 | -5,081 | N/A | 29,316 | N/A |
12/31/2015 | 209,940 | -7,471 | N/A | 31,432 | N/A |
9/30/2015 | 208,432 | 14,365 | N/A | 30,324 | N/A |
6/30/2015 | 206,193 | 16,713 | N/A | 31,320 | N/A |
3/31/2015 | 204,667 | 16,002 | N/A | 29,261 | N/A |
12/31/2014 | 204,911 | 16,454 | N/A | 27,867 | N/A |
9/30/2014 | 204,342 | 14,813 | N/A | 28,711 | N/A |
6/30/2014 | 203,997 | 14,350 | N/A | 28,080 | N/A |
3/31/2014 | 203,371 | 15,322 | N/A | 28,723 | N/A |
12/31/2013 | 200,277 | 15,391 | N/A | 29,857 | N/A |
9/30/2013 | 197,123 | 15,412 | N/A | 31,189 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: MRCH.F is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.5%).
Ertrag vs. Markt: MRCH.F is forecast to become profitable over the next 3 years, which is considered above average market growth.
Hohe Wachstumserträge: MRCH.F is expected to become profitable in the next 3 years.
Einnahmen vs. Markt: MRCH.F's revenue (3.5% per year) is forecast to grow slower than the US market (8.7% per year).
Hohe Wachstumseinnahmen: MRCH.F's revenue (3.5% per year) is forecast to grow slower than 20% per year.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: MRCH.F's Return on Equity is forecast to be low in 3 years time (5.6%).